SCHEMBL25908442

SCHEMBL25908442

C=C(C)C(F)S(=O)(=O)c1ccc(OCCN2CCC3(CC2)C(=O)Nc2ccccc23)cc1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 11/20 0.43
HTR2A P28223 11/20 0.43
HTR7 P34969 11/20 0.43
HTR6 P50406 11/20 0.43
MMP1 P03956 3/20 0.41
MMP9 P14780 3/20 0.41
MMP13 P45452 3/20 0.41
ADAM17 P78536 3/20 0.41
OPRM1 P35372 1/20 0.40
OPRK1 P41145 1/20 0.40
OPRL1 P41146 1/20 0.40
HRH3 Q9Y5N1 2/20 0.40
KCNH2 Q12809 1/20 0.39
LTA4H P09960 1/20 0.38
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA7 P43166 1/20 0.38
CA9 Q16790 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25318723 0.89 HTR1A (0.46) HTR1AHTR2AHTR7HTR6MMP1
SCHEMBL25317717 0.84 HTR1A (0.48) HTR1AHTR2AHTR7HTR6MMP1
SCHEMBL25315766 0.81 HRH3 (0.48) HTR1AHTR2AHTR7HTR6OPRM1
SCHEMBL25315078 0.76 HTR1A (0.42) HTR1AHTR2AHTR7HTR6HRH3
SCHEMBL30507061 0.76 HTR1A (0.42) HTR1AHTR2AHTR7HTR6HRH3
SCHEMBL25908381 0.76 HTR1A (0.41) HTR1AHTR2AHTR7HTR6OPRM1
SCHEMBL25317666 0.75 ALK (0.42) HTR2AHRH3KCNH2CA12CA1
SCHEMBL25316295 0.75 HTR1A (0.47) HTR1AHTR2AHTR7HTR6OPRM1
SCHEMBL4772435 0.73 HTR1A (0.54) HTR1AHTR2AHTR7HTR6OPRM1
SCHEMBL25928826 0.73 MEN1 (0.41) HTR1AHTR2AHTR7HTR6MMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023141432-A2 APOL1 INHIBITORS AND METHODS OF USE MAZE THERAPEUTICS, INC. (US) 2023-07-27 WO disclosed